Targeting Glioblastoma: Inducing Necroptosis molecular pathway Post- Photodynamic Therapy for Enhanced Neurosurgical and Therapeutic Outcomes

Abstract Glioblastoma (GBM) remains a formidable challenge in neurosurgery and oncology due to its aggressive progression and resistance to standard therapies. This study investigates the potential of enhancing photodynamic therapy (PDT) efficacy by inducing necroptosis—a regulated form of necrotic cell death—in glioblastoma stem cells (GSCs). We hypothesize that combining PDT with necroptosis induction could overcome the limitations of conventional approaches by targeting resistant tumor cell populations, ultimately improving clinical outcomes. This work provides insights into the molecular mechanisms underlying this combinatorial strategy and its potential translational impact in GBM treatment.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-20
DOI
https://doi.org/10.5281/zenodo.13901954
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting Glioblastoma: Inducing Necroptosis molecular pathway Post- Photodynamic Therapy for Enhanced Neurosurgical and Therapeutic Outcomes

Zenodo (CERN European Organization for Nuclear Research)
Photodynamic Therapy Research Studies
article

Targeting Glioblastoma: Inducing Necroptosis molecular pathway Post- Photodynamic Therapy for Enhanced Neurosurgical and Therapeutic Outcomes

article en

Abstract

Abstract Glioblastoma (GBM) remains a formidable challenge in neurosurgery and oncology due to its aggressive progression and resistance to standard therapies. This study investigates the potential of enhancing photodynamic therapy (PDT) efficacy by inducing necroptosis—a regulated form of necrotic cell death—in glioblastoma stem cells (GSCs). We hypothesize that combining PDT with necroptosis induction could overcome the limitations of conventional approaches by targeting resistant tumor cell populations, ultimately improving clinical outcomes. This work provides insights into the molecular mechanisms underlying this combinatorial strategy and its potential translational impact in GBM treatment.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 52%
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.